Showing results (251-260 of 2,397) with videos related to
Sort By:
Pageof 240
Translational Lung Cancer Research|March 4, 2022
High efficacy of alectinib in a patient with advanced lung adenocarcinoma with 2 rare ALK fusion sites: a case reportYan Li, Peng Duan, Yan Guan, et al.Translational Lung Cancer Research|June 19, 2019
Implementing smoking cessation within cancer treatment centres and potential economic impactsWilliam K Evans, Rebecca Truscott, Erin Cameron, et al.Translational Lung Cancer Research|June 19, 2019
Tobacco and the lung cancer epidemic in ChinaMark Parascandola, Lin XiaoTranslational Lung Cancer Research|September 19, 2018
A quantitative method for assessing smoke associated molecular damage in lung cancersKai Song, Jia-Hao Bi, Zhe-Wei Qiu, et al.Translational Lung Cancer Research|April 14, 2023
Strategies to overcome resistance to ALK inhibitors in non-small cell lung cancer: a narrative reviewAakash Desai, Christine M LovlyTranslational Lung Cancer Research|April 14, 2023
CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancerAkihiro Nagoya, Ryota Sada, Hirokazu Kimura, et al.Translational Lung Cancer Research|April 14, 2023
Prognostic value of L4 lymph node dissection during video-assisted thoracoscopic surgery in patients with left-sided non-small cell lung cancer: a single-center, retrospective cohort studyJia-Di Wu, Cai-Yan Fang, Zhi-Chao Li, et al.Translational Lung Cancer Research|April 14, 2023
Transformation of ALK-positive NSCLC to SCLC after alectinib resistance and response to combined atezolizumab: a case reportGuohao Xia, Jiayuan Huang, Jie Ni, et al.Translational Lung Cancer Research|April 14, 2023
Sustainably released nanoparticle-based rhynchophylline limits pulmonary fibrosis by inhibiting the TEK-PI3K/AKT signaling pathwayShuo Wang, Zhanghao Huang, Yifei Liu, et al.Translational Lung Cancer Research|April 14, 2023
Rhabdomyolysis in a patient with advanced lung cancer treated with osimertinib: a case reportYou Li, Yu Liu, Zichen Zhao, et al.Pageof 240